Entrada Therapeutics Inc (TRDA) — Net Asset Momentum
Entrada Therapeutics Inc (TRDA) recorded a net asset momentum of 76.9% as of December 2024, with net assets of $428.68 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Entrada Therapeutics Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Entrada Therapeutics Inc Net Asset Momentum (2019–2024)
This chart tracks Entrada Therapeutics Inc's year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is +76.9%, with net assets of $428.68 Million USD as of December 2024. Read TRDA liabilities breakdown for a breakdown of total debt and financial obligations.
Annual Net Asset History for Entrada Therapeutics Inc (2019–2024)
The table below shows the complete annual net asset history for Entrada Therapeutics Inc from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see TRDA company net worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $428.68 Million | $526.32 Million | $97.64 Million | ▲ +76.9% |
| 2023 | $242.36 Million | $469.19 Million | $226.83 Million | ▲ +14.0% |
| 2022 | $212.55 Million | $252.06 Million | $39.50 Million | ▼ -28.8% |
| 2021 | $298.72 Million | $305.83 Million | $7.12 Million | ▲ +820.0% |
| 2020 | $-41.49 Million | $43.53 Million | $85.02 Million | ▼ -167.4% |
| 2019 | $-15.52 Million | $18.24 Million | $33.76 Million | — |